Mikkael A. Sekeres, Chief, Division of Hematology at Sylvester Comprehensive Cancer Center, shared on X:
“How to best determine if someone is benefitting from MDSsm therapy? Amer Zeidan tackles this question at the Miami Leukemia Symposium!”
Read more about MDSsm on OncoDaily.